About Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes
Clinical Trials at Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes
During the past decade, Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes"
#1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes
According to Clinical.Site data, the most researched conditions in "Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes" are
"Antibody-mediated Rejection" (1 trials), "Multiple System Atrophy" (1 trials), "Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID)" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes" in a lesser frequency.
Clinical Trials Intervention Types at Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes
Most popular intervention types in "Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes" are "Drug" (2 trials), "Biological" (1 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Blood samples" (1 trials), "Clazakizumab" (1 trials), "FACS analyses" (1 trials), "Physiologic saline solution" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes
The vast majority of trials in "Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes" are
4 trials for "All" genders.
Clinical Trials Status at Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes
Currently, there are NaN active trials in "Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hopitaux Universitaire de Strasbourg-Centre de References des Maladies Autoimmunes, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".